Drug Database
Back to search

Ireland· IE-PA-PA22668/014/001

Femoston 1/10mg film-coated tablets

A dydrogesteron und estrogen product containing dydrogesterone + estradiol, registered in Ireland by Theramex Ireland Limited. The same ATC class is registered in 9 of our 19 countries.

ATC G03FB08

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedFemoston 1/10mg film-coated tabletsATCG03FB08REGISTER NO.IE-PA-PA22668/014/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dydrogesterone + estradiolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dydrogesteron und estrogen is registered in 9 of 19 countries.

Countries holding a registration under ATC G03FB08 (dydrogesteron und estrogen), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 6 of them publish a price we can compare per daily dose
Search dydrogesteron und estrogen products by name

Dydrogesteron und estrogen · ATC G03FB08

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Dydrogesterone + Estradiol
Manufacturer
Theramex Ireland Limited
Country
Ireland (IE)
ATC code
G03FB08
ATC class
Dydrogesteron und Estrogen
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA22668/014/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for dydrogesteron und estrogen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dydrogesteron und estrogen against other medicinesHow interaction checks work

Dydrogesteron und estrogen · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Dydrogesteron und estrogen in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dydrogesteron und estrogen products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Femoston, Femoston Conti
  • Belgium · Femoston, Femoston 2/10
  • Cyprus · Femoston
  • Czechia · Femoston, Femoston Conti
  • Germany · Femoston, Femoston Conti
  • Denmark · Femoston, Femoston Conti
  • Estonia · Femoston, Femoston Conti
  • Spain · Femfascon, Femoston
  • Finland · Femoston, Femoston Conti
  • France · Climaston
  • Greece · Femaston
  • Croatia · Femoston, Femoston Conti
  • Italy · Femoston, Femoston Conti
  • Lithuania · Femoston, Femoston Conti
  • Luxembourg · Femoston, Femoston Conti
  • Latvia · Femoston, Femoston Conti
  • Malta · Femoston, Femoston-Conti
  • Netherlands · Femoston, Femoston Continu
  • Norway · Femoston, Femostonconti
  • Poland · Femoston, Femoston Conti
  • Portugal · Femoston
  • Sweden · Femoston, Femostonconti
  • Slovenia · Femphascon Conti
  • Slovakia · Femoston, Femoston Conti

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/972760c7-6f90-4d7d-a450-4c2f915402fb
GET /v1/drugs/972760c7-6f90-4d7d-a450-4c2f915402fb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "G03FB",
    "G03FB08"
  ],
  "strength": null,
  "pa_number": "PA22668/014/001",
  "substances": [
    "Dydrogesterone",
    "Estradiol"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "23/01/1998",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about dydrogesteron und estrogen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console